Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Ovarian Neoplasms 24Uterine Cervical Neoplasms 18Fallopian Tube Neoplasms 15Endometrial Neoplasms 13Neoplasm Metastasis 9Breast Neoplasms 9Pancreatic Neoplasms 8Uterine Cervical Dysplasia 6Melanoma 6Colorectal Neoplasms 6Prostatic Neoplasms 5Stomach Neoplasms 4Precancerous Conditions 4Carcinosarcoma 4Carcinoma, Renal Cell 4Vulvar Neoplasms 3Uterine Neoplasms 3Urinary Bladder Neoplasms 3Triple Negative Breast Neoplasms 3Squamous Intraepithelial Lesions 3Sarcoma 3Salivary Gland Neoplasms 3Neoplasms 3Carcinoma, Ovarian Epithelial 3Carcinoma, Non-Small-Cell Lung 3Anus Neoplasms 3Squamous Cell Carcinoma of Head and Neck 2Skin Neoplasms 2Rectal Neoplasms 2Papillomavirus Infections 2

Interventions

pembrolizumab 5Nivolumab 2tislelizumab 1sintilimab 1durvalumab 1dostarlimab 1denileukin diftitox 1avelumab 1atezolizumab 1Taxes 1Paclitaxel 1Megestrol Acetate 1Medroxyprogesterone Acetate 1Interleukin-2 1Immune Checkpoint Inhibitors 1E7777 fusion protein 1Docetaxel 1Carboplatin 1Biopsy 1ALT-803 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Turcot syndrome × Biopsy × Gynecologic × Clear all
NCT04906382 2025-02-13

Tislelizumab for the Treatment of Recurrent Mismatch Repair Deficient Endometrial Cancer

Ohio State University Comprehensive Cancer Center

Phase EARLY_PHASE1 Terminated
2 enrolled
GastrointestinalGynecologic

Turcot syndrome, Colorectal Neoplasms, Hereditary Nonpolyposis, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡